Answer
It is licensed for certain adults with previously treated, locally advanced or metastatic non-small cell lung cancer carrying a KRAS G12C mutation.
Sources for this answer
- LUMYKRAS 240 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.